Effectiveness of Mindfulness Based Cognitive Therapy on Perceived Stress and Quality of Life Related to the Skin Disease of Women with Psoriasis

Document Type : Research Paper

Authors

1 Department of Clinical Psychology,Islamic Azad University, Khorasgan,Isfahan, Iran

2 Faculty member of Clinical Psychology, Community Health Research Center, Islamic Azad University, Isfahan Branch (Khorasgan), Isfahan, Iran

3 1 Skin Diseases and Leishmaniasis Research Center( SDLRC), Isfahan University of Medical Sciences, Isfahan, Iran 2 Medical Education Research Center(MERC), Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Introduction:Psoriasis is a chronic and recurrent disease that has an effect on the body, mental and quality of life of patients. The purpose of this study was to investigate the effect of mindfulness based cognitive therapy on perceived stress and quality of life associated with the disease of women with psoriasis referring to Isfahan Dermatology Research Center.
Methods: The research design was quasi-experimental using pre-test and post-test with control group and one-month follow-up. For this purpose, 30 patients who referred to the Dermatology and Cutaneous Leishmaniosis Research Center of Isfahan during 2017 were selected through convenience sampling and randomly assigned into experimental and control groups (each including 15 individuals). All participants responded to (IPQ), Dermatology Life Quality Index (DLQI) and Cohen Perceived Stress Scale in three stages, namely pre-test, post-test and follow-up. The experimental group attended in 8 focused therapies (Segal, Williams & Teasdale therapeutic package 2002) biweekly. Control group did not receive any intervention until the end of the follow-up phase. The data were analyzed by repeated measure analysis of variance.
Results: The results revealed that mindfulness-based cognitive therapy significantly reduces perceived stress and enhanced the disease-related quality of life in the experimental group compared with the control group(p < 0.001)
Conclusion: According to the results of this study, which showed that while the effect of mindfulness-based therapy is significant for improving and reducing perceived stress and improving the quality of life associated with psoriasis, this treatment was also effective in the follow-up phase and its effect was continuous.
 

Keywords

References

  1. Fordham B.A.The role of Mindfulness based cognitive therapy in the management of
    Psoriasis, the university of Manchester. (2012). 116-119.
    2. Bundy C, Pinder B, Bucci S, Reeves D, Griffiths C.E.M, Tarrier N. A novel, web‐based,
    psychological intervention for people with psoriasis: the electronic Targeted Intervention for
    Psoriasis (e TIP s) study. Br J Dermatol. 2013;169(2):329-36.
    3. Kim H.J. & Lebwohl M.G. Biologics and Psoriasis the Beat Goes on. Dermatologic Clinics.
    2019; 37(1):29-36.
    4. Sarafino E. Psycology of Health, Translating Elahe Mirzaee et al., Tehran: Growth
    Publication. 2008.
    5.Al-Mutairi N, Al-Faraq S, Al-Mutairi A, Al-Shiltawy M. Comorbidities associated with
    psoriasis: an experience from the Middle East. J Dermatol 2010; 37: 146–155.
  2. 6.Rosenstock I.M. The health belief model: explaining health behavior through
    expectancies.1990.
    7. Naldi L., Chatenoud L., Linder D., Belloni F. A., Peserico A., Virgili A. R., et al. Cigarette
    smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an
    Italian case–control study. J Invest Dermatol. 2005; 125(1):61-7.
    8. Rigopoulos D, Gregoriou S, Katrinaki A, Korfitis C., Larios G., Stamou C., et al.
    Characteristics of psoriasis in Greece: an epidemiological study of a population in a sunny
    Mediterranean climate. Eur J Dermatol. 2010 ;1;20(2):189-95.
    9.Ghajarzadeh M, Kheirkhah S, Ghyiasi M. Quality of life and depression in patients with
    vitiligo. jdc. 2011; 2 (4) :203-209
    10. Barrea L., Nappi F., Di Somma C., Savanelli M. C., Falco A., Balato A., et al. Environmental
    risk factors in psoriasis: the point of view of the nutritionist. Int J Environ Res Public Health.
    2016; 22;13(7):743
    11. Oliveira Mde F, Rocha Bde O, Duarte GV. Psoriasis: classical and emerging comorbidities.
    An Bras Dermatol 2015; 90: 9–20.
    12. Menter A., Korman N.J., Elmets C.A., Feldman S.R., Gelfand J.M., Gordon K.B., et al.
    Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines
    of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and
    evidence-based conclusions. J Am Acad Dermatol 2011; 65: 137–174
    13.Nast A., Gisondi P., Ormerod A.D., Splus P.I., Gisondi P., Paul C., et al. European S3-
    Guidelines on the systemic treatment of psoriasis vulgaris–Update 2015–Short version–EDF in
    cooperation with EADV and IPC. J Eur Acad Dermatol Venereol 2015; 29: 2277–2294.
    14.Mrowietz U., Barker J., Boehncke W.H., Iversen L., Kirby B., Naldi L., et al. Clinical use of
    dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a European expert consensus. J
    Eur Acad Dermatol Venereol 2018; 32(Suppl 3): 3–14.
    15.Mrowietz U, Szepietowski JC, Loewe R., Van de Kerkhof P., Lamarca R., Ocker W.G., et al.
    Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic
    plaque psoriasis: a randomized, double-blind, Fumaderm(R) - and placebo-controlled trial
    (BRIDGE). Br J Dermatol 2017; 176: 615–623.
    16.European Medicines Agency (EMA). EPAR summary for the public: Skilarence, dimethyl
    fumarate. URL
    http://www.ema.europa.eu/docs/en_GB/document_library/EPAR__Summary_for_the_public/hu
    man/ 002157/WC500231110.pdf (last accessed: 2017 July 2018).
    17.Feldman SR, Krueger GG. Psoriasis assessment tools in clinical trials. Ann Rheum Dis 2005;
    64(Suppl 2): ii65–ii68; discussion ii69-73.
    18. Oji V, Luger TA. The skin in psoriasis: assessment and challenges. Clin Exp Rheumatol
    2015; 33: S14–S19.
    19.Feldman S.R., Fleischer A.B., Reboussin D.M., Bradham D.D., Exum M.L., Clark A.R. The
    economic impact of psoriasis increases with psoriasis severity. J Am Acad Dermatol 1997; 37:
    564–569.
    20. Gelfand J.M., Feldman S.R., Stern R.S., Thomas J., Rolstad T., Margolis D.J. Determinants
    of quality of life in patients with psoriasis: a study from the US population. J Am Acad of
    Dermatol. 2004; 51(5):704-708.
    21. Mohammad Khanei P., Khannipour H. Mind-focused treatments. Tehran: Publications of
    University of Welfare. 2012.
    22. Fortune D.G., Richards H.L., Kirby B., Bowcock S., Main C.J. & Griffiths C.E. A
    cognitive‐behavioural symptom management programme as an adjunct in psoriasis therapy. Br J
    Dermatol. 2002;146(3):458-65.
    23.Kwon C.W., Fried R.G., Nousari Y., Ritchlin C. & Tausk F. Psoriasis: Psychosomatic,
    somatopsychic, or both? Clin Dermatol 2018; 36(6): 698-703.
    24.Dahlgaard J., Jørgensen M.M., Velden A.M., Sumbundu A., Gregersen N., Olsen R.K.,et al.
    Mindfulness, health, and longevity. In the science of hormesis in health and longevity. Academic
    Press 2019; 243-55. 19.
    25.Ivtzan I., Young T., Martman J., Jeffrey A., Lomas T., Hart R., et al. Integrating mindfulness
    into positive psychology: A randomised controlled trial of an online positive mindfulness
    program. Mindfulness 2016; 7(6): 1396-1407. 20.
    26.Kashdan T.B., Ciarrochi J.V., editors. Mindfulness, acceptance, and positive psychology: The
    seven foundations of well-being. New Harbinger Publications. 2013.
    27. Williams J.M., Duggan D.S., Crane C. & Fennell M.J. Mindfulness‐Based cognitive therapy
    for prevention of recurrence of suicidal behavior. J clin psychol. 2006;62(2):201-10.
    28.Gaylord S.A., Palsson O.S., Garland E.L., Faurot K.R., Coble R.S., Mann J.D., et al.
    Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a
    randomized controlled trial. Am J Gastroenterol. 2011;106(9):1678.
    29. Alibeige-Beni E., Salehi A. & Jafary F. The Effect of Mindfulness-Based Stress Reduction
    Program on Emotional WellBeing (Stress, Anxiety, Depression, and Sadness) of Patients with
    Psoriasis. Journal of Isfahan Medical School.21735(436):756-762.
    30.Greeson J.M., Smoski M.J. & Suarez E.C., Brantley J.G., Ekblad A.G., Lynch T.R, et al.
    Decreased symptoms of depression after mindfulness-based stress reduction: potential
    moderating effects of religiosity, spirituality, trait mindfulness, sex, and age. J Altern
    Complement Med. 2015;21(3):166-74.
    31.Kaviani H., Javaheri F. & Bahraini H. The effectiveness of cognitive-based cognitive therapy
    is to reduce their thoughts. Negative, ineffective attitude, depression and anxiety follow-up 60
    days. Journal of Cognitive Sciences, (2005). 1 (7): 58-49.
    32. Villasenor-Park Jennifer, Wheeler David, Grandinetti Lisa, "Psoriasis: Evolving treatment
    for a complex disease “. Cleveland Clinic Journal of Medicine, 2012; 79 (6):413-423.
    33. Segal ZV, Williams JMG. & Teasdale JD. Mindfulness-Based Cognitive therapy for
    depression: A new approach to preventing relapse New York: Guilford Press. (2002).
    34. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc
    Behav. 1983; 1:385-96.
    35.Bastani F., Rahmatnejad L., Jesmi F., Haghani H. Breastfeeding Self efficacy and Perceived
    Stress. Iranian Journal of Nursing. 2008.21(54). pp:9-22.
    36. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)—a simple practical measure
    for routine clinical use. Clinical and experimental dermatology. 1994;19(3):210-6.
    37. Aghaei S, Sodaifi M, Jafari P, Mazharinia N, Finlay AY. DLQI scores in vitiligo: reliability
    and validity of the Persian version. BMC dermatol. 2004;4(1):8.
    38. Sohrabi F., Jaffari Fard S., Zareei S. & Eskandari H. The effectiveness of mindfulness based
    cognitive therapy on panic disorder. Journal of Clinical Psychology. 2013.4(16):31-43.
    39. Smits J.A., Minhajuddin A., Jarrett R.B. Cognitive therapy for depressed adults with
    comorbid social phobia. J Affect Disord. 2009;114(1-3):271-8.
    40. Grossman P., Niemann L., Schmidt S. & Walach H. Mindfulness-based stress reduction and
    health benefits: A meta-analysis. J Psychosom Res. 2004 Jul 1;57(1):35-43.
  3. 41.Kabat-Zinn J. Mindfulness‐based interventions in context: past, present, and future. Clinical
    psychology: Science and practice. 2003;10(2):144-56.
medical journal of mashhad university of medical sciences
Volume 63, Issue 3
July and August 2020
Pages 2428-2440

Files

Share

How to cite

Statistics